author-photo

Charles Peterfy

University of California, San Francisco

235

Papers

14939

Citations

Citation Trend

Filter By

Papers (160) Sort By

Journal Conference Others

POS0087 LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 3 YEARS FROM THE SELECT-COMPARE STUDY

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Non-invasive vagus nerve stimulation for rheumatoid arthritis: a proof-of-concept study

2021
Show All
- Source
- Cite
- Save
Citations (3)
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis.

2021 Arthritis Research & Therapy
Show All
- Source
- Cite
- Save
Citations (7)
Results from Phase 1 Extension Study Assessing Pexidartinib Treatment in 6 cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Safety and efficacy of neurostimulation with a miniaturised vagus nerve stimulation device in patients with multidrug-refractory rheumatoid arthritis: a two-stage multicentre, randomised pilot study

2020
Show All
- Source
- Cite
- Save
Citations (25)
P225 Inhibition of structural joint damage with upadacitinib as monotherapy or in combination with MTX in patrients with RA: one-year outcomes from the select Phase 3 programme

2020 Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
Long‐term outcomes of pexidartinib in tenosynovial giant cell tumors

2020 Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Pexidartinib for advanced tenosynovial giant cell tumor (TGCT): Long-term efficacy and safety from the phase 3 ENLIVEN and phase 1 PLX108-01 (TGCT cohort) studies.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
THU0188 INHIBITION OF STRUCTURAL JOINT DAMAGE WITH UPADACITINIB AS MONOTHERAPY OR IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS: 1 YEAR OUTCOMES FROM THE SELECT PHASE 3 PROGRAM

2019 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Safety and Efficacy of Repeat Administration of Triamcinolone Acetonide Extended-release in Osteoarthritis of the Knee: A Phase 3b, Open-label Study.

2019
Show All
- Source
- Cite
- Save
Citations (11)